Senator Kirsten Gillibrand announced the Capping Prescription Costs Act, which would limit annual out-of-pocket drug expenses to $2,000 for individuals and $4,000 for families with private insurance. The bill aims to make life-saving medications more affordable for Americans.
Gillibrand criticized rising drug prices, arguing that no one should have to skip doses due to cost. She highlighted past efforts, including the Inflation Reduction Act, which capped Medicare drug costs and allowed price negotiations. The new bill builds on these measures to protect more patients.
Co-sponsored by several Democratic senators, the legislation seeks to ease financial burdens for those with chronic conditions. Gillibrand vowed to continue fighting for lower drug prices and expanded healthcare access.